Co-Diagnostics, Inc. Common Stock (CODX)vsMedtronic PLC (MDT)
CODX
Co-Diagnostics, Inc. Common Stock
$5.63
-2.26%
HEALTHCARE · Cap: $20.75M
MDT
Medtronic PLC
$81.67
-0.16%
HEALTHCARE · Cap: $94.69B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 4940791% more annual revenue ($35.48B vs $718,170). MDT leads profitability with a 13.0% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 61/100 (C+).
CODX
Hold38
out of 100
Grade: F
MDT
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CODX.
Margin of Safety
+10.3%
Fair Value
$89.60
Current Price
$81.67
$7.93 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 190.3% year-over-year
Conservative balance sheet, low leverage
Earnings expanding 30.8% YoY
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.1B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
ROE of -302.3% — below average capital efficiency
Weak financial health signals
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : CODX
The strongest argument for CODX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 190.3% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : CODX
The primary concerns for CODX are Market Cap, Profit Margin, Piotroski F-Score.
Bear Case : MDT
The primary concerns for MDT are Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
CODX profiles as a hypergrowth stock while MDT is a value play — different risk/reward profiles.
CODX carries more volatility with a beta of 1.26 — expect wider price swings.
CODX is growing revenue faster at 190.3% — sustainability is the question.
MDT generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (61/100 vs 38/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Co-Diagnostics, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?